S189: early, deep, and durable responses, and low rates of crs with regn5458, a bcmaxcd3 bispecific antibody, in a phase 1/2 first-in-human study in patients with relapsed/refractory multiple myeloma
HemaSphere(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要